Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: ULTRAGENYX PHARMACEUTICAL INC., ULTRAGENYX PHARMACEUTICAL, INC., ULTRAGENYX PHARMACEUTICAL INC., ULTRAGENYX PHARMACEUTICAL, INC.
Client-Reported Lobbying Expenses
$2.3M
28 filings
Firm Income Reported for This Client
$550K
Not substituted for client expenses
SEC Insider
$166.9M
1,157 transactions
Summary
ULTRAGENYX PHARMACEUTICAL INC. (RARE) is an organization. Its political footprint includes $2.3 million in client-reported lobbying expenses, $550K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Budget/Appropriations, Medicare/Medicaid. Their largest government contract source is Department of Veterans Affairs at $0. Political activity spans from 2018 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↑ 68% YoY
2025: $740K (complete years)
Insider Trading
31 insiders